Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infection
Authors:
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Cytotherapy
- Vol. 23 (11) , 980-984
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protectionCell, 2021
- Recent endemic coronavirus infection is associated with less-severe COVID-19Journal of Clinical Investigation, 2021
- Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, FranceEmerging Infectious Diseases, 2021
- COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literatureTransplantation Reviews, 2021
- Evidence of potent humoral immune activity in COVID-19-infected kidney transplant recipientsAmerican Journal of Transplantation, 2020
- COVID-19 in an international European liver transplant recipient cohortGut, 2020
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed IndividualsCell, 2020
- A A Multicentre ICET-A Study of Confirmed SARS-CoV-2 Infection in Patients with Hemoglobinopathies: Preliminary Data from 10 CountriesMediterranean Journal of Hematology and Infectious Diseases, 2020
- Prolonged Shedding of Human Coronavirus in Hematopoietic Cell Transplant Recipients: Risk Factors and Viral Genome EvolutionThe Journal of Infectious Diseases, 2017
- Significant Transplantation-Related Mortality from Respiratory Virus Infections within the First One Hundred Days in Children after Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2015